Circulating osteoprotegerin levels and cardiovascular outcomes in patients with pre-dialysis chronic kidney disease: results from the KNOW-CKD study

被引:0
作者
Suh, Sang Heon [1 ,2 ]
Oh, Tae Ryom [1 ,2 ]
Choi, Hong Sang [1 ,2 ]
Kim, Chang Seong [1 ,2 ]
Bae, Eun Hui [1 ,2 ]
Ma, Seong Kwon [1 ,2 ]
Oh, Kook-Hwan [3 ]
Lee, Kyu-Beck [4 ]
Jeong, Jong Cheol [5 ]
Jung, Ji Yong [6 ]
Kim, Soo Wan [1 ,2 ]
机构
[1] Chonnam Natl Univ, Dept Internal Med, Med Sch, 42 Jebongro, Gwangju 61469, South Korea
[2] Chonnam Natl Univ Hosp, 42 Jebongro, Gwangju 61469, South Korea
[3] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[4] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Div Nephrol,Sch Med, Seoul, South Korea
[5] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Div Nephrol, Seongnam, South Korea
[6] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Incheon, South Korea
基金
新加坡国家研究基金会;
关键词
Biomarker; Chronic kidney disease; Major adverse cardiac event; Osteoprotegerin; CORONARY-ARTERY CALCIFICATION; SERUM OSTEOPROTEGERIN; HEART-FAILURE; PLASMA OSTEOPROTEGERIN; RISK; MORTALITY; EVENTS; BIOMARKERS; BONE; ASSOCIATION;
D O I
10.1038/s41598-024-54335-y
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
While the relationship between circulating osteoprotegerin (OPG) and cardiovascular events is well-established in the general population, its association with cardiovascular risks in chronic kidney disease (CKD) patients remains less robust. This study hypothesized that elevated circulating OPG levels might be associated with an increased risk of major adverse cardiac events (MACE) in CKD patients, a total of 2,109 patients with CKD stages 1 through pre-dialysis 5 from the KNOW-CKD cohort were categorized into quartiles based on serum OPG levels. The primary outcome of the study was 3-point MACE, defined as a composite of nonfatal myocardial infarction, nonfatal stroke, or cardiac death. The median follow-up duration was 7.9 years. The cumulative incidence of 3-point MACE significantly varied across serum OPG levels in Kaplan-Meier curve analysis (P < 0.001, log-rank test), with the highest incidence observed in the 4th quartile. Cox regression analysis indicated that, relative to the 1st quartile, the risk of 3-point MACE was significantly higher in the 3rd (adjusted hazard ratio 2.901, 95% confidence interval 1.009 to 8.341) and the 4th quartiles (adjusted hazard ratio 4.347, 95% confidence interval 1.410 to 13.395). In conclusion, elevated circulating OPG levels are associated with adverse cardiovascular outcomes in pre-dialysis CKD patients.
引用
收藏
页数:11
相关论文
共 41 条
[1]   Relationship between serum osteoprotegerin, glycemic control, renal function and markers of atherosclerosis in type 2 diabetes [J].
Altinova, Alev E. ;
Toruner, Fusun ;
Akturk, Mujde ;
Bukan, Neslihan ;
Yetkin, Ilhan ;
Cakir, Nuri ;
Arslan, Metin .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2011, 71 (04) :340-343
[2]   Osteoprotegerin regulates vascular function through syndecan-1 and NADPH oxidase-derived reactive oxygen species [J].
Alves-Lopes, Rheure ;
Neves, Karla Bianca ;
Strembitska, Anastasiya ;
Harvey, Adam P. ;
Harvey, Katie Y. ;
Yusuf, Hiba ;
Haniford, Susan ;
Hepburn, Ross T. ;
Dyet, Jennifer ;
Beattie, Wendy ;
Haddow, Laura ;
McAbney, John ;
Graham, Delyth ;
Montezano, Augusto C. .
CLINICAL SCIENCE, 2021, 135 (20) :2429-2444
[3]   Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice [J].
Bennett, Brian J. ;
Scatena, Marta ;
Kirk, Elizabeth A. ;
Rattazzi, Marcello ;
Varon, Rebecca M. ;
Averill, Michelle ;
Schwartz, Stephen M. ;
Giachelli, Cecilia M. ;
Rosenfeld, Michael E. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (09) :2117-2124
[4]   Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women [J].
Browner, WS ;
Lui, LY ;
Cummings, SR .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (02) :631-637
[5]   Increased Calcification in Osteoprotegerin-Deficient Smooth Muscle Cells: Dependence on Receptor Activator of NF-κB Ligand and Interleukin 6 [J].
Callegari, Andrea ;
Coons, Matthew L. ;
Ricks, Jerry L. ;
Rosenfeld, Michael E. ;
Scatena, Marta .
JOURNAL OF VASCULAR RESEARCH, 2014, 51 (02) :118-131
[6]   The Correlation of Serum Osteoprotegerin with Non-Traditional Cardiovascular Risk Factors and Arterial Stiffness in Patients with Pre-Dialysis Chronic Kidney Disease: Results from the KNOW-CKD Study [J].
Chae, Seung Yun ;
Chung, WooKyung ;
Kim, Yeong Hoon ;
Oh, Yun Kyu ;
Lee, Joongyub ;
Choi, Kyu Hun ;
Ahn, Curie ;
Kim, Yong-Soo .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2018, 33 (53)
[7]   Multiple Plasma Biomarkers for Risk Stratification in Patients With Heart Failure and Preserved Ejection Fraction [J].
Chirinos, Julio A. ;
Orlenko, Alena ;
Zhao, Lei ;
Basso, Michael D. ;
Cvijic, Mary Ellen ;
Li, Zhuyin ;
Spires, Thomas E. ;
Yarde, Melissa ;
Wang, Zhaoqing ;
Seiffert, Dietmar A. ;
Prenner, Stuart ;
Zamani, Payman ;
Bhattacharya, Priyanka ;
Kumar, Anupam ;
Margulies, Kenneth B. ;
Car, Bruce D. ;
Gordon, David A. ;
Moore, Jason H. ;
Cappola, Thomas P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) :1281-1295
[8]   Plasma osteoprotegerin, its correlates, and risk of heart failure: a prospective cohort study [J].
Di Giuseppe, Romina ;
Biemann, Ronald ;
Wirth, Janine ;
Menzel, Juliane ;
Isermann, Berend ;
Stangl, Gabriele I. ;
Fritsche, Andreas ;
Boeing, Heiner ;
Schulze, Matthias B. ;
Weikert, Cornelia .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2017, 32 (02) :113-123
[9]   Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases [J].
Dutka, Mieczyslaw ;
Bobinski, Rafal ;
Wojakowski, Wojciech ;
Francuz, Tomasz ;
Pajak, Celina ;
Zimmer, Karolina .
HEART FAILURE REVIEWS, 2022, 27 (04) :1395-1411
[10]   Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled [J].
Elewa, Usama ;
Dolores Sanchez-Nino, Maria ;
Martin-Cleary, Catalina ;
Fernandez-Fernandez, Beatriz ;
Egido, Jesus ;
Ortiz, Alberto .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (06) :1731-1744